Cannabinoids showed no clear difference in absence of nausea ( compared with placebo (low certainty).
Cannabinoids may leads to higher participant preference ( compared with other anti‐emetic agent (low certainty).
Cannabinoids may leads to higher withdrawal any reason ( compared with other anti‐emetic agent (low certainty).
It is very uncertain whether cannabinoids changes withdrawal due to lack of efficacy ( compared with other anti‐emetic agent (very low certainty).
Cannabinoids may leads to higher withdrawal due to adverse event ( compared with other anti‐emetic agent (low certainty).
Cannabinoids may leads to higher absence of vomiting ( compared with placebo (low certainty).
Cannabinoids probably leads to higher absence of nausea and vomiting ( compared with placebo (moderate certainty).
Cannabinoids may leads to higher participant preference ( compared with placebo (low certainty).
It is very uncertain whether cannabinoids changes withdrawal any reason ( compared with placebo (very low certainty).
It is very uncertain whether cannabinoids changes withdrawal due to adverse event ( compared with placebo (very low certainty).
Cannabinoids showed no clear difference in absence of nausea ( compared with other anti‐emetic agent (low certainty).
Cannabinoids showed no clear difference in absence of vomiting ( compared with other anti‐emetic agent (moderate certainty).
Cannabinoids showed no clear difference in absence of nausea and vomiting ( compared with other anti‐emetic agent (low certainty).
It is very uncertain whether cannabinoid plus other anti‐emetic agent changes absence of nausea ( compared with other anti‐emetic monotherapy (very low certainty).
Cannabinoid plus other anti‐emetic agent showed no clear difference in absence of vomiting ( compared with other anti‐emetic monotherapy (low certainty).
Cannabinoid plus other anti‐emetic agent showed no clear difference in absence of nausea and vomiting ( compared with other anti‐emetic monotherapy (low certainty).
Cannabinoid plus other anti‐emetic agent showed no clear difference in withdrawal any reason ( compared with other anti‐emetic monotherapy (low certainty).
It is very uncertain whether cannabinoid plus other anti‐emetic agent changes withdrawal due to adverse event ( compared with other anti‐emetic monotherapy (very low certainty).
Cannabinoid plus other anti‐emetic agent showed no clear difference in withdrawal due to lack of efficacy ( compared with other anti‐emetic monotherapy (low certainty).